GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pangaea Oncology SA (XMAD:PANG) » Definitions » PB Ratio

Pangaea Oncology (XMAD:PANG) PB Ratio : 2.20 (As of May. 05, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Pangaea Oncology PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-05), Pangaea Oncology's share price is €1.47. Pangaea Oncology's Book Value per Share for the quarter that ended in Jun. 2023 was €0.67. Hence, Pangaea Oncology's PB Ratio of today is 2.20.

The historical rank and industry rank for Pangaea Oncology's PB Ratio or its related term are showing as below:

XMAD:PANG' s PB Ratio Range Over the Past 10 Years
Min: 1.95   Med: 3.18   Max: 5.82
Current: 2.2

During the past 10 years, Pangaea Oncology's highest PB Ratio was 5.82. The lowest was 1.95. And the median was 3.18.

XMAD:PANG's PB Ratio is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 2.125 vs XMAD:PANG: 2.20

During the past 12 months, Pangaea Oncology's average Book Value Per Share Growth Rate was -19.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 15.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 6.30% per year.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Pangaea Oncology was 86.80% per year. The lowest was -4.80% per year. And the median was 15.70% per year.

Back to Basics: PB Ratio


Pangaea Oncology PB Ratio Historical Data

The historical data trend for Pangaea Oncology's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pangaea Oncology PB Ratio Chart

Pangaea Oncology Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.42 3.45 3.61 2.51 1.95

Pangaea Oncology Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.51 2.51 1.92 1.95 2.20

Competitive Comparison of Pangaea Oncology's PB Ratio

For the Diagnostics & Research subindustry, Pangaea Oncology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pangaea Oncology's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pangaea Oncology's PB Ratio distribution charts can be found below:

* The bar in red indicates where Pangaea Oncology's PB Ratio falls into.



Pangaea Oncology PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Pangaea Oncology's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=1.47/0.669
=2.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Pangaea Oncology  (XMAD:PANG) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Pangaea Oncology PB Ratio Related Terms

Thank you for viewing the detailed overview of Pangaea Oncology's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pangaea Oncology (XMAD:PANG) Business Description

Traded in Other Exchanges
N/A
Address
Calle Sabino Arana, 5-19, Barcelona, ESP, 08028
Pangaea Oncology SA is a medical services company. The company provides a wide range of services to cancer patients, as well as global pharmaceutical and biotech clients, in the fields of molecular diagnostics, clinical trials, in vitro drug profiling, dx platform validation, and biomarker discovery. The company has aggregated its operations into two segments, Clinical Care division and Diagnostic and Research and Development services division. Clinical Care division delivers medical oncology services and related activities. Diagnostic and Research and Development services division provides diagnostic and in-vitro services.

Pangaea Oncology (XMAD:PANG) Headlines

No Headlines